Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological Malignancy
Author:
- 1 April 1995
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 153 (4) , 1085-1096
Abstract
No abstract availableThis publication has 101 references indexed in Scilit:
- Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I TrialJNCI: Journal of the National Cancer Institute, 1993
- Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6).Journal of Cell Biology, 1993
- ORIGIN OF URINARY EPIDERMAL GROWTH FACTOR IN HUMANS: EXCRETION OF ENDOGENOUS EGF AND INFUSED [131I]‐HUMAN EGF AND KIDNEY HISTOCHEMISTRYClinical and Experimental Pharmacology and Physiology, 1992
- Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitroMolecular Endocrinology, 1992
- Transforming Growth Factor-β Stimulates Production of Insulin-Like Growth Factor-Binding Protein-3 by Human Skin Fibroblasts*Endocrinology, 1991
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- Production and significance of TGF-β in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinomaBiochemical and Biophysical Research Communications, 1990
- Androgens modulate epidermal growth factor receptor levels in the rat ventral prostateMolecular and Cellular Endocrinology, 1988
- Transforming growth factor type β in normal human urineBiochemical and Biophysical Research Communications, 1987
- Urine from Patients with Transitional-Cell Carcinoma Stimulates Migration of Capillary Endothelial CellsNew England Journal of Medicine, 1981